Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−42 JPY
−7.19 B JPY
12.77 B JPY
74.68 M
About NXERA PHARMA CO LTD
Sector
CEO
Chris Cargill
Headquarters
Tokyo
Website
Founded
1990
ISIN
JP3431300007
FIGI
BBG000Q25Z21
Sosei Group Corporation is a holding company primarily engaged in the biopharmaceutical business. The Company is mainly involved in the research, development and sale of pharmaceutical drugs, including NVA237 and QVA149, used for chronic obstructive pulmonary disease; SO - 1105, used for oral thrush. As of March 31, 2013, the Company had three consolidated subsidiaries.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4565 is 1,034 JPY — it has decreased by −1.71% in the past 24 hours. Watch NXERA PHARMA CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange NXERA PHARMA CO LTD stocks are traded under the ticker 4565.
4565 stock has fallen by −1.90% compared to the previous week, the month change is a −6.85% fall, over the last year NXERA PHARMA CO LTD has showed a −26.56% decrease.
We've gathered analysts' opinions on NXERA PHARMA CO LTD future price: according to them, 4565 price has a max estimate of 3,900.00 JPY and a min estimate of 1,300.00 JPY. Watch 4565 chart and read a more detailed NXERA PHARMA CO LTD stock forecast: see what analysts think of NXERA PHARMA CO LTD and suggest that you do with its stocks.
4565 reached its all-time high on May 9, 2016 with the price of 6,545 JPY, and its all-time low was 23 JPY and was reached on Oct 28, 2008. View more price dynamics on 4565 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4565 stock is 2.23% volatile and has beta coefficient of 0.89. Track NXERA PHARMA CO LTD stock price on the chart and check out the list of the most volatile stocks — is NXERA PHARMA CO LTD there?
Today NXERA PHARMA CO LTD has the market capitalization of 92.96 B, it has decreased by −2.12% over the last week.
Yes, you can track NXERA PHARMA CO LTD financials in yearly and quarterly reports right on TradingView.
NXERA PHARMA CO LTD is going to release the next earnings report on Feb 18, 2025. Keep track of upcoming events with our Earnings Calendar.
4565 earnings for the last quarter are 13.45 JPY per share, whereas the estimation was 0.28 JPY resulting in a 4.68 K% surprise. The estimated earnings for the next quarter are 8.30 JPY per share. See more details about NXERA PHARMA CO LTD earnings.
NXERA PHARMA CO LTD revenue for the last quarter amounts to 9.26 B JPY, despite the estimated figure of 12.56 B JPY. In the next quarter, revenue is expected to reach 10.85 B JPY.
4565 net income for the last quarter is 1.20 B JPY, while the quarter before that showed −1.42 B JPY of net income which accounts for 184.39% change. Track more NXERA PHARMA CO LTD financial stats to get the full picture.
No, 4565 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 350.00 employees. See our rating of the largest employees — is NXERA PHARMA CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NXERA PHARMA CO LTD EBITDA is −1.26 B JPY, and current EBITDA margin is −51.56%. See more stats in NXERA PHARMA CO LTD financial statements.
Like other stocks, 4565 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NXERA PHARMA CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NXERA PHARMA CO LTD technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NXERA PHARMA CO LTD stock shows the strong sell signal. See more of NXERA PHARMA CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.